EU Firms Called In As Coronavirus Cases Soar
Potential Vaccines, Diagnostics And Repurposed Drug Compounds Sought
With cases of novel coronavirus infection rising at an alarming rate, the industry in Europe is being urged to contribute what it can by way of new products for detecting, diagnosing or treating the disease. Several research projects are also being run or started up with EU funding.
You may also be interested in...
As fears grow that a full-blown COVID-19 pandemic may be on the way, a European public-private consortium is to make available a total of €45m (US$49m) in funding for projects aimed at accelerating the development of diagnostics and therapeutics to help tackle the current outbreak and any future coronavirus threats.
Europe’s Innovative Medicines Initiative is calling for R&D projects aimed at tackling the spread of COVID-19, saying that collaborative ventures have the potential to accelerate the development of therapeutics and diagnostics to tackle this and future coronavirus outbreaks.
Europe’s Innovative Medicines Initiative is to get €90m in funding for programs targeting the coronavirus outbreak.